Legend Biotech Corporation
LEGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $287 | $1,278 | $786 | $689 |
| Short-Term Investments | $836 | $31 | $240 | $193 |
| Receivables | $125 | $157 | $45 | $59 |
| Inventory | $24 | $19 | $10 | $2 |
| Other Curr. Assets | $12 | $13 | $19 | $7 |
| Total Curr. Assets | $1,284 | $1,498 | $1,099 | $950 |
| Property Plant & Equip (Net) | $202 | $190 | $162 | $143 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $174 | $4 | $69 | $17 |
| Long-Term Investments | $4 | $4 | $0 | $5 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $152 | $1 | $5 |
| Total NC Assets | $386 | $351 | $232 | $170 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,670 | $1,849 | $1,331 | $1,119 |
| Liabilities | – | – | – | – |
| Payables | $37 | $20 | $32 | $7 |
| Short-Term Debt | $5 | $3 | $4 | $1 |
| Tax Payable | $24 | $7 | $11 | $10 |
| Deferred Revenue | $47 | $53 | $0 | $0 |
| Other Curr. Liab. | $164 | $133 | $251 | $211 |
| Total Curr. Liab. | $278 | $216 | $298 | $229 |
| LT Debt | $346 | $325 | $281 | $122 |
| Deferred Rev, NC | $6 | $55 | $8 | $2 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $352 | $381 | $289 | $124 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $49 | $47 | $24 | $3 |
| Total Liabilities | $630 | $597 | $587 | $354 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,662 | -$1,485 | -$966 | -$520 |
| AOCI | -$68 | $99 | $15 | $5 |
| Other Equity | $2,770 | $2,637 | $1,696 | $1,281 |
| Total Equity | $1,041 | $1,251 | $744 | $766 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,670 | $1,849 | $1,331 | $1,119 |
| Net Debt | $64 | -$949 | -$501 | -$566 |